Your browser doesn't support javascript.
loading
Exploring factors associated with health disparities in asthma and poorly controlled asthma among school-aged children in the U.S.
Sullivan, P W; Ghushchyan, V; Navaratnam, P; Friedman, H S; Kavati, A; Ortiz, B; Lanier, B.
Afiliação
  • Sullivan PW; Regis University School of Pharmacy, Denver, Colorado, USA.
  • Ghushchyan V; University of Colorado, Denver, Colorado, USA.
  • Navaratnam P; American University of Armenia, Yerevan, Armenia.
  • Friedman HS; DataMed Solutions LLC, New York, New York, USA.
  • Kavati A; DataMed Solutions LLC, New York, New York, USA.
  • Ortiz B; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Lanier B; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
J Asthma ; 57(3): 271-285, 2020 03.
Article em En | MEDLINE | ID: mdl-30732486
ABSTRACT

Objective:

Certain populations suffer disproportionately from asthma and asthma morbidity. The objective was to provide a national descriptive profile of asthma control and treatment patterns among school-aged children (SAC aged 6-17) in the U.S.

Methods:

This was a cross-sectional analysis using the nationally representative 2007-2014 Medical Expenditure Panel Survey. Among SAC with asthma, indicators of poor control included exacerbation/asthma attack; >3 canisters short-acting beta agonist (SABA)/3 months; and asthma-specific Emergency Department or inpatient visits (ED/IP).

Results:

Non-Hispanic black, non-Hispanic multiple races, Puerto Rican, obese, Medicaid, poor, ≥2 non-asthma chronic comorbidities (CC), and family average CC ≥ 2 were associated with higher odds of having asthma. The following had significantly higher odds ratios (OR) of excessive SABA use compared to non-Hispanic whites [OR; CI; p < 0.05] Puerto Rican (3.8; 2.1-6.9), Mexican (3.6; 2.0-6.4), Central/South American (3.0; 1.2-7.7), Hispanic-other (3.1; 1.1-9.0), non-Hispanic black (2.5; 1.6-3.9), and non-Hispanic Asian (4.0; 1.7-9.2). SABA OR were also significant for Spanish spoken at home (2.5; 1.6-3.8), obese (2.1; 1.3-3.3), Medicaid (2.9; 2.0-4.1), no medical insurance (2.1; 1.1-4.1), no prescription insurance (2.5; 1.8-3.5), poor (2.8; 1.7-4.7), CC ≥ 2 (2.1; 1.6-2.8), parent-without high-school degree (2.5; 1.8-3.6), parent-SF-12 Physical Component Scale <50 (1.6; 1.2-2.1) and Mental Component Scale <50 (1.5; 1.1-2.0). Significant differences also existed across subgroups for ED/IP visits.

Conclusions:

There are disparities in asthma control and prevalence among certain populations in the U.S. These results provide national data on disparities in several indicators of poor asthma control beyond the standard race/ethnicity groupings.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Disparidades nos Níveis de Saúde Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: J Asthma Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Disparidades nos Níveis de Saúde Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Child / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: J Asthma Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos